Cardiopulmonary bypass (CPB) is used increasingly to correct cyanotic heart defects during early infancy, but myocardial dys-function is often seen after surgical repair. This study evaluates whether starting CPB at a conventional, hyperoxic P02 cause
AbstractObjective: Hyperoxic cardiopulmonary bypass is widely used during cardiac operations in the ...
Abstract Background The aim of this study was to characterize the influence of cardiopulmonary bypas...
Aims: S100B has been proposed as a consolidated marker of brain damage in infants with congenital he...
IntroductionAbrupt reoxygenation of cyanotic infants on cardiopulmonary bypass (CPB) is followed by ...
WOS: 000326410100004Background: This study aims to investigate the effects of controlled reoxygenati...
ObjectiveSingle-ventricle patients undergoing pediatric heart surgery are a high-risk group owing to...
Background: This study aims to investigate the effects of controlled reoxygenation cardiopulmonary b...
ObjectivesThis study investigates the effects of controlled reoxygenation cardiopulmonary bypass on ...
AbstractThis study of an in vivo infantile piglet model of compensated hypoxemia tests the hypothesi...
AbstractThe immature heart is more tolerant to ischemia than the adult heart, yet infants with cyano...
Cyanotic congenital heart disease comprises a diverse spectrum of anatomical pathologies. Common to ...
The development of the cardiopulmonary bypass (CPB) revolutionized cardiac surgery and contributed i...
AbstractThis study tests the hypothesis that reoxygenation of cyanotic immature hearts when starting...
AbstractThis study tested the hypothesis that the developing heart is susceptible to oxygen-mediated...
AbstractThe conventional way to start cardiopulmonary bypass is to prime the cardiopulmonary bypass ...
AbstractObjective: Hyperoxic cardiopulmonary bypass is widely used during cardiac operations in the ...
Abstract Background The aim of this study was to characterize the influence of cardiopulmonary bypas...
Aims: S100B has been proposed as a consolidated marker of brain damage in infants with congenital he...
IntroductionAbrupt reoxygenation of cyanotic infants on cardiopulmonary bypass (CPB) is followed by ...
WOS: 000326410100004Background: This study aims to investigate the effects of controlled reoxygenati...
ObjectiveSingle-ventricle patients undergoing pediatric heart surgery are a high-risk group owing to...
Background: This study aims to investigate the effects of controlled reoxygenation cardiopulmonary b...
ObjectivesThis study investigates the effects of controlled reoxygenation cardiopulmonary bypass on ...
AbstractThis study of an in vivo infantile piglet model of compensated hypoxemia tests the hypothesi...
AbstractThe immature heart is more tolerant to ischemia than the adult heart, yet infants with cyano...
Cyanotic congenital heart disease comprises a diverse spectrum of anatomical pathologies. Common to ...
The development of the cardiopulmonary bypass (CPB) revolutionized cardiac surgery and contributed i...
AbstractThis study tests the hypothesis that reoxygenation of cyanotic immature hearts when starting...
AbstractThis study tested the hypothesis that the developing heart is susceptible to oxygen-mediated...
AbstractThe conventional way to start cardiopulmonary bypass is to prime the cardiopulmonary bypass ...
AbstractObjective: Hyperoxic cardiopulmonary bypass is widely used during cardiac operations in the ...
Abstract Background The aim of this study was to characterize the influence of cardiopulmonary bypas...
Aims: S100B has been proposed as a consolidated marker of brain damage in infants with congenital he...